A clinical trial of ethambutol plus capreomycin in the treatment of atypical tuberculosis.
D000328:Adult; D000368:Aged; D000995:Antitubercular Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003523:Cycloserine / Q000009:adverse effects; D004977:Ethambutol / Q000008:administration & dosage*; D005000:Ethionamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology
D000995:Antitubercular Agents; D010455:Peptides; D004977:Ethambutol; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid